Achaogen is a startup based in the United States, 2 tracked investors.
Based in the United States, Achaogen is a startup. Brouky records 2 investors associated with the company.
Achaogen develops antibiotic treatments, including ZEMDRI® (plazomicin), which is approved in the US for treating complicated urinary tract infections caused by certain multidrug-resistant Enterobacterales bacteria.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.